Literature DB >> 6486314

Management of stage T3 and T4 glottic carcinomas.

A Yuen, J E Medina, H Goepfert, G Fletcher.   

Abstract

Between 1959 and 1979, 242 patients with T3 and T4 lesions of the vocal cords were treated at our institution. Treatment consisted of total laryngectomy in all patients. Different modalities of regional node dissections were performed on 187 patients. In addition, 50 patients received irradiation with cobalt-60 postoperatively for specific features of the disease. In the group of 192 patients whose treatment consisted of surgery alone, 28 (14 percent) had recurrence in the neck and 10 (5 percent) had stomal recurrence. Of the patients treated with combined therapy, three (6 percent) had ipsilateral neck recurrences and one (2 percent) had stomal recurrence. For lesions staged N0, failure rates above the clavicles were 16 percent and 31 percent for patients with T3 and T4 lesions, respectively, in the group treated by surgery alone, 9 percent and 6 percent for patients with T3 and T4 lesions, respectively, in the combined therapy group. The rate of failure above the clavicles for lesions staged N+ was 32 percent in the group treated with surgery alone and 8 percent in the combined therapy group. In this study, a correlation was made between the failure rates above the clavicles and different clinical and histologic characteristics of the tumor, surgical findings, and the different modalities of cervical node dissection used. From analysis of the data, recommendations have been made for the selective treatment of patients with advanced glottic carcinomas.

Entities:  

Mesh:

Year:  1984        PMID: 6486314     DOI: 10.1016/0002-9610(84)90371-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  6 in total

1.  Voice after laryngectomy.

Authors:  M Gleeson
Journal:  BMJ       Date:  1992-01-04

2.  Staging of laryngeal cancer: endoscopy, computed tomography and magnetic resonance versus histopathology.

Authors:  P Zbären; M Becker; H Läng
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

3.  Functional utility and oncologic safety of near-total laryngectomy with tracheopharyngeal speech shunt in a Third World oncologic center.

Authors:  A M Shenoy; P K Plinkert; N Nanjundappa; S Premalata; G R Arunodhay
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 4.  Advanced larynx cancer.

Authors:  Scott E Strome; Eric C Weinman
Journal:  Curr Treat Options Oncol       Date:  2002-02

5.  Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion.

Authors:  Francis P Worden; Jeffrey Moyer; Julia S Lee; Jeremy M G Taylor; Susan G Urba; Avraham Eisbruch; Theodoros N Teknos; Douglas B Chepeha; Mark E Prince; Norman Hogikyan; Amy Anne D Lassig; Kevin Emerick; Suresh Mukherji; Lubomir Hadjiski; Christina I Tsien; Tamara H Miller; Nancy E Wallace; Heidi L Mason; Carol R Bradford; Gregory T Wolf
Journal:  Laryngoscope       Date:  2009-08       Impact factor: 3.325

Review 6.  Impact of cartilage invasion on treatment and prognosis of laryngeal cancer.

Authors:  J A Castelijns; M Becker; R Hermans
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.